Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-9-22
|
pubmed:abstractText |
Atopic asthma is characterized by inflammatory responses of the airway and is associated with up-regulation of Th2 cytokines, notably IL-4 and IL-5. A recently described human cytokine, IL-13, is a potent in vitro modulator of various cell types, including monocytes, B cells, and endothelial cells. Similar to IL-4, it is also involved in the induction of IgE synthesis. However, the in vivo expression and function of IL-13 and its relation to disease remain to be defined. Using a segmental allergen challenge model, we have examined the in vivo expression of IL-13 in the bronchoalveolar lavage (BAL) cells of atopic patients. We found a significant enhancement of both IL-13 transcripts and secreted proteins in the allergen-challenged BAL compared with the saline-challenged control sites of asthmatic and rhinitic patients. In contrast, the expression of IL-13 transcripts was not detected in the BAL of two normal subjects challenged with the same dose of ragweed allergen. The cellular source of IL-13 mRNA was identified in the mononuclear cell fraction of the allergen-challenged BAL. The allergen-induced quantitative differences in the level of transcripts were confirmed by competitive PCR assays. These results suggest that the significant increase in IL-13 in the allergen-challenged BAL is primarily from the mononuclear cells and is involved in the regulation of allergen-induced late phase inflammatory responses.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
155
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2688-94
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7650396-Adult,
pubmed-meshheading:7650396-Allergens,
pubmed-meshheading:7650396-Asthma,
pubmed-meshheading:7650396-Base Sequence,
pubmed-meshheading:7650396-Bronchial Provocation Tests,
pubmed-meshheading:7650396-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:7650396-Eosinophils,
pubmed-meshheading:7650396-Female,
pubmed-meshheading:7650396-Humans,
pubmed-meshheading:7650396-Hypersensitivity, Immediate,
pubmed-meshheading:7650396-Interleukin-13,
pubmed-meshheading:7650396-Male,
pubmed-meshheading:7650396-Molecular Sequence Data,
pubmed-meshheading:7650396-Polymerase Chain Reaction,
pubmed-meshheading:7650396-RNA, Messenger,
pubmed-meshheading:7650396-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:7650396-Up-Regulation
|
pubmed:year |
1995
|
pubmed:articleTitle |
IL-13 expression at the sites of allergen challenge in patients with asthma.
|
pubmed:affiliation |
Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|